Alyeska Investment Group
SCMP

Alyeska Investment Group’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Alyeska Investment Group’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-39,644
Closed -$712K – 568
2017
Q4 		$712K Buy
+39,644
New +$488K 0.01% 396

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Alyeska Investment Group's SCMP Position: Q1 2018 in Review

Alyeska Investment Group sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 39,644 shares — an estimated $712K sold.

Alyeska Investment Group first reported a position in SCMP in Q4 2017 and held it in 1 quarter. The position peaked at $712K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Alyeska Investment Group reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Alyeska Investment Group sold 39,644 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $712K.
  • Alyeska Investment Group first reported a position in Sucampo Pharmaceuticals, Inc. in Q4 2017 and held it in 1 quarter.
  • Alyeska Investment Group's Sucampo Pharmaceuticals, Inc. position peaked at $712K in Q4 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Alyeska Investment Group's 13F filing for Q1 2018, filed 15 May 2018.